Hematology
Clinical Topics & News
Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy?
Epoetin alfa and darbepoetin alfa are erythropoiesis-stimulating agents (ESAs), approved for the treatment of anemia (low red blood cells [RBCs])...
Conference Coverage
Colorectal cancer: New observations, new implications
We may need to consider expanding our risk concepts to include not only genetic and personal risk factors but also environmental factors.
Article
Former Smokers Motivate Quitters
CDC campaign uses peer-to-peer influence to increase quit rates among smokers.
Resources
Hematology and Oncology Federal Health Data Trends
Cancer research is a high priority for the DoD and especially for the VA.
Article
Are We Beating Cancer—Finally?
Although some cancer incidence rates are still high, death rates are on a decline.
Digital Edition
Advances in Hematology and Oncology (May 2018)
Commentary
Thirteen Years and Still Growing: An AVAHO History
The Association of VA Hematology/Oncology (AVAHO) is now 13 years old, and we have much to celebrate!
Article
What Makes Squamous Cell Cancers Different? Genomics May Explain
New analytic tools and data use genetic signatures to help researchers distinguish the differences among various cancers.
Article
Giving Dexamethasone a New Lease on Life
New findings support the idea of changing treatment for adverse effects of chemotherapy to a treatment for fighting the cancer.
Clinical Topics & News
Clinical Puzzle: Lung Cancer or Hodgkin Lymphoma?
Making the right diagnosis when radiologic evidence is misleading.
